The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice
Open accessAbstract
The 8th edition of the American Joint Committee on Cancer (AJCC) staging of epithelial cancers of the esophagus and esophagogastric junction (EGJ) presents separate classifications for clinical (cTNM), pathologic (pTNM), and postneoadjuvant (ypTNM) stage groups. Histopathologic cell type markedly affects survival of clinically and pathologically staged patients, requiring separate groupings for each cell type, but ypTNM groupings are identical for both cell types. Clinical categories, typically obtained by imaging with minimal histologic information, are limited by resolution of each method. Strengths and shortcomings of clinical staging methods should be recognized. Complementary cytology or histopathology findings may augment imaging and aid initial treatment decision-making. However, prognostication using clinical stage groups remains coarse and inaccurate compared with pTNM. Pathologic staging is losing its relevance for advanced-stage cancer as neoadjuvant therapy replaces esophagectomy alone. However, it remains relevant for early-stage cancers and as a staging and survival reference point. Although pathologic stage could facilitate decision-making, its use to direct postoperative adjuvant therapy awaits more effective treatment. Prognostication using pathologic stage groups is the most refined of all classifications. Postneoadjuvant staging (ypTNM) is introduced by the AJCC but not adopted by the Union for International Cancer Control (UICC). Drivers of this addition include absence of equivalent pathologic (pTNM) categories for categories peculiar to the postneoadjuvant state (ypT0N0-3M0 and ypTisN0-3M0), dissimilar stage group compositions, and markedly different survival profiles. Thus, prognostication is specific for patients undergoing neoadjuvant therapy. The role of ypTNM classification in additional treatment decision-making is currently limited. Precision cancer care advances are necessary for this information to be clinically useful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
Mandard, A.-M., Dalibard, F., Mandard, J.-C., Marnay, J., Henry-Amar, M., Petiot, J.-F., Roussel, A., Jacob, J.-H., Segol, P., Samama, G., et al. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c · Cited by 2,044
ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus
Shaheen, N. J., Falk, G. W., Iyer, P. G., & Gerson, L. B. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.322 · Cited by 1,501
Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Pimentel-Nunes, P., Dinis-Ribeiro, M., Ponchon, T., Repici, A., Vieth, M., De Ceglie, A., Amato, A., Berr, F., Bhandari, P., Bialek, A., et al. (2015) · Endoscopy · doi:10.1055/s-0034-1392882 · Cited by 1,329
Endosonography-guided fine-needle aspiration biopsy: Diagnostic accuracy and complication assessment
Wiersema, M., Vilmann, P., Giovannini, M., Chang, K., & Wiersema, L. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70164-1 · Cited by 1,131
TNM Classification of Malignant Tumours.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-1-248_1 · Cited by 1,094
Ryan, R., Gibbons, D., Hyland, J. M. P., Treanor, D., White, A., Mulcahy, H. E., O'Donoghue, D. P., Moriarty, M., Fennelly, D., & Sheahan, K. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02176.x · Cited by 726
International Union Against Cancer (UICC)
Turner, B. (2012) · The Statesman’s Yearbook · doi:10.1007/978-1-349-59541-9_43 · Cited by 720
Flamen, P., Lerut, A., Van Cutsem, E., De Wever, W., Peeters, M., Stroobants, S., Dupont, P., Bormans, G., Hiele, M., De Leyn, P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3202 · Cited by 571
Staging investigations for oesophageal cancer: a meta-analysis
van Vliet, E. P. M., Heijenbrok-Kal, M. H., Hunink, M. G. M., Kuipers, E. J., & Siersema, P. D. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604200 · Cited by 517
Optimum Lymphadenectomy for Esophageal Cancer
Rizk, N. P., Ishwaran, H., Rice, T. W., Chen, L.-Q., Schipper, P. H., Kesler, K. A., Law, S., Lerut, T. E. M. R., Reed, C. E., Salo, J. A., et al. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181b2f6ee · Cited by 461
Self-citationPuli, S. R., Reddy, J. B., Bechtold, M. L., Antillon, D., Ibdah, J. A., & Antillon, M. R. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1479 · Cited by 387
Kelly, S., Harris, K. M., Berry, E., Hutton, J., Roderick, P., Cullingworth, J., Gathercole, L., & Smith, M. A. (2001) · Gut · doi:10.1136/gut.49.4.534 · Cited by 366
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Flanagan, F. L., Dehdashti, F., Siegel, B. A., Trask, D. D., Sundaresan, S. R., Patterson, G. A., & Cooper, J. D. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.2.9016218 · Cited by 312
Kato, H., Kuwano, H., Nakajima, M., Miyazaki, T., Yoshikawa, M., Ojima, H., Tsukada, K., Oriuchi, N., Inoue, T., & Endo, K. (2002) · Cancer · doi:10.1002/cncr.10330 · Cited by 309
Rice, T. W., Ishwaran, H., Hofstetter, W. L., Kelsen, D. P., Apperson-Hansen, C., Blackstone, E. H., & for the Worldwide Esophageal Cancer Collaboration Investigators (2016) · Diseases of the Esophagus · doi:10.1111/dote.12533 · Cited by 280
Self-citation(1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00974-1 · Cited by 235
Rice, T. W., Ishwaran, H., Blackstone, E. H., Hofstetter, W. L., Kelsen, D. P., & Apperson-Hansen, C. (2016) · Diseases of the Esophagus · doi:10.1111/dote.12540 · Cited by 146
Self-citationEsophageal Cancer: Associations With (pN+) Lymph Node Metastases
Rice, T. W., Ishwaran, H., Hofstetter, W. L., Schipper, P. H., Kesler, K. A., Law, S. Y.-K., Lerut, A., Denlinger, C. E., Salo, J., Scott, W. J., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001594 · Cited by 130
Self-citationOesophageal adenocarcinoma and gastric cancer: should we mind the gap?
Hayakawa, Y., Sethi, N. S., Sepulveda, A. R., Bass, A. J., & Wang, T. C. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.24 · Cited by 122
Wu, T., Chirieac, L. R., Abraham, S. C., Krasinskas, A. M., Wang, H., Rashid, A., Correa, A. M., Hofstetter, W. L., Ajani, J. A., & Swisher, S. G. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213312.36306.cc · Cited by 119
Rice, T. W., Ishwaran, H., Kelsen, D. P., Hofstetter, W. L., Apperson-Hansen, C., & Blackstone, E. H. (2016) · Diseases of the Esophagus · doi:10.1111/dote.12538 · Cited by 107
Self-citationChirieac, L. R., Swisher, S. G., Correa, A. M., Ajani, J. A., Komaki, R. R., Rashid, A., Hamilton, S. R., & Wu, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1840 · Cited by 81
Chang, F., Deere, H., Mahadeva, U., & George, S. (2008) · American Journal of Clinical Pathology · doi:10.1309/ccr3qn4874yjdjj7 · Cited by 64
Barbour, A. P., Rizk, N. P., Gerdes, H., Bains, M. S., Rusch, V. W., Brennan, M. F., & Coit, D. G. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.05.010 · Cited by 55
The endoscopic diagnosis and staging of oesophageal adenocarcinoma
Bergman, J. J. G. H. M. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.04.010 · Cited by 25
Cited by
Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline
Shah, M. A., Kennedy, E. B., Catenacci, D. V., Deighton, D. C., Goodman, K. A., Malhotra, N. K., Willett, C., Stiles, B., Sharma, P., Tang, L., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00866 · Cited by 333
Esophageal carcinoma: Towards targeted therapies
Fatehi Hassanabad, A., Chehade, R., Breadner, D., & Raphael, J. (2020) · Cellular Oncology · doi:10.1007/s13402-019-00488-2 · Cited by 158
Metadata
- Authors
- Rice, T. W., Patil, D. T., & Blackstone, E. H.
- Venue
- Annals of Cardiothoracic Surgery
- Publisher
- AME Publishing Company
- Published
- 2017-03
- Volume
- 6
- Issue
- 2
- Pages
- 119-130
- ISSN
- 2225-319X (ISSN-L)
- 2304-1021
- OpenAlex
- W2604296489
- Cited by
- 782
- References
- 26
- FWCI
- 42.45
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.